Pierce Biotechnology, Inc.
45 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3
Ending by 2030
Jul 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jun 8, 2027The maintenance fee for Modified nucleotides methods and kits (US 9,206,216) comes due Jun 8, 2027. Unpaid by Dec 8, 2027, it lapses early.
- 2 fees due Aug 2, 2027
- 1 fee due Sep 22, 2027The maintenance fee for Electroblot transfer buffer (US 9,291,596) comes due Sep 22, 2027. Unpaid by Mar 22, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 18, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,960,519 | Extraction of cellular components with fatty acid derivatives In force · From the USPTO record | In force | From the USPTO record | |
| US 8,007,998 | Polymerized conjugates for biological applications In force · From the USPTO record | In force | From the USPTO record | |
| US 7,745,153 | Pyrocatechol violet-metal protein assay In force · From the USPTO record | In force | From the USPTO record | |
| US 8,507,291 | Detergent removal from protein samples prior to mass spectrometry analysis In force · From the USPTO record | In force | From the USPTO record | |
| US 9,828,633 | Modified nucleotides methods and kits In force · From the USPTO record | In force | From the USPTO record | |
| US 8,572,507 | Systems and methods for interacting with dynamic protocols In force · From the USPTO record | In force | From the USPTO record | |
| US 8,536,323 | Modified nucleotides In force · From the USPTO record | In force | From the USPTO record | |
| US 8,945,861 | Methods for isotopically labeling biomolecules using mammalian cell-free extracts In force · From the USPTO record | In force | From the USPTO record | |
| US 9,206,216 | Modified nucleotides methods and kits In force · From the USPTO record | In force | From the USPTO record | |
| US 9,248,407 | Dialysis Device In force · High confidence | In force | High confidence |
Also on record, not counted in the 18: 45 patents in force now held by others · 1 lapsed for an unpaid fee · 37 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
10 pending · 3 abandoned · 15 no status recorded